Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis. | Nat Commun | 2023 | 37872166 | PubTator, text mining | PubMed |
| CD4+CD25+FOXP3+ regulatory T cells: a potential "armor" to shield "transplanted allografts" in the war against ischemia reperfusion injury. | Front Immunol | 2023 | 37868962 | PubTator, text mining | PubMed |
| Clinical and Pathologic Response to Vedolizumab in a Young Female Patient With Collagenous Gastritis. | ACG Case Rep J | 2023 | 37868366 | PubTator, text mining | PubMed |
| Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study. | Crohns Colitis 360 | 2023 | 37859629 | PubTator, text mining | PubMed |
| Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches. | Microbiome Res Rep | 2023 | 37849974 | PubTator, text mining | PubMed |
| Role of Biologic Therapies in the Rheumatic Manifestations of Inflammatory Bowel Disease: A Systematic Analysis. | Cureus | 2023 | 37842480 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
| Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. | J Clin Med | 2023 | 37835065 | PubTator, text mining | PubMed |
| HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria. | Nat Commun | 2023 | 37816704 | PubTator, text mining | PubMed |
| Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. | Cell Commun Signal | 2023 | 37770930 | PubTator, text mining | PubMed |
| Multitissue H3K27ac profiling of GTEx samples links epigenomic variation to disease. | Nat Genet | 2023 | 37770633 | PubTator, text mining | PubMed |
| Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. | Pharmaceuticals (Basel) | 2023 | 37765080 | PubTator, text mining | PubMed |
| Therapeutic Antibodies in Medicine. | Molecules | 2023 | 37764213 | PubTator, text mining | PubMed |
| Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37739811 | PubTator, text mining | PubMed |
| Human gut-associated lymphoid tissue: A dynamic hub propagating modulators of inflammation. | Clin Transl Med | 2023 | 37735775 | PubTator, text mining | PubMed |
| A novel monoclonal antibody against 6-sulfo sialyl Lewis x glycans attenuates murine allergic rhinitis by suppressing Th2 immune responses. | Sci Rep | 2023 | 37735247 | PubTator, text mining | PubMed |
| Pathological mechanism and targeted drugs of ulcerative colitis: A review. | Medicine (Baltimore) | 2023 | 37713856 | PubTator, text mining | PubMed |
| Nitrilium ion trapping as a strategy to access structurally diverse heterobiaryl-containing peptide macrocycles. | Chem Sci | 2023 | 37712035 | PubTator, text mining | PubMed |
| [Prepubertal gynecomastia at the debut of hereditary tumors predisposition syndrome (clinical case reports)]. | Probl Endokrinol (Mosk) | 2023 | 37694873 | PubTator, text mining | PubMed |
| HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis. | Int J Mol Sci | 2023 | 37686454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=7